A PLOS Biology study finds that cancer researchers tend to overestimate the extent to which preclinical studies may be reproducible.
In Nucleic Acids Research this week: MicrobiomeAnalyst, Cancer PanorOmics, and more
One speaker cited the success of screening Ashkenazi Jewish women for BRCA mutations, but another said extending testing to a wider population could be harder.
Researchers have released new tools for analyzing epigenomic data as part of the International Human Epigenome Consortium.
Using genotyping data, a McGill University-led team examined the ancestry and movements of African-American populations.
Nearly 8,000 patients participated in a screening study that used a PCR-based detection assay from Becton Dickinson, uncovering a 5 percent carrier rate.
Two recent studies confirm that CRISPR/Cas9 can edit and inhibit latent HIV provirus, but one of them hints that the virus can develop resistance to excision.
Genome sequence data revealed a single Mycobacterium tuberculosis introduction to northern Quebec in the early 20th century, without a subsequent rise in virulence.
In Nature this week: UK10K project data enables study of novel variants, and more.
The researchers published a proof of principle in Nature Communications of a panel designed to look at epigenetic variation in adipose tissue and are using it to study obesity and metabolic syndromes.
Gene drives might run into biological resistance, the Economist reports.
Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.
Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.
In Science this week: full CRISPR locus integration complex structure, and more.